Times of India
Abbott to pay $385M to settle US claims over infant formula plant
Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns. Abbott…
View original source — Times of India ↗
Related stories
The Guardian
ScienceSep 10, 2026 · 1 min
Chemical companies reach $455m settlement with North Carolina over ‘forever chemicals’ claims
The Guardian
South China Morning Post
WorldSep 9, 2026 · 1 min
Singapore’s DBS sued for US$1 billion in alleged 1MDB-linked claim
South China Morning Post
The Guardian
HealthSep 11, 2026 · 1 min
Customers of UK-owned surrogacy firm in Mexico allegedly face huge bills after insurance denied
The Guardian
Bloomberg
BusinessSep 8, 2026 · 1 min
Major Food Companies Allege US Sugar Producers Colluded on Price
Bloomberg